Corrigendum: TET-catalyzed 5-hydroxymethylcytosine regulates gene expression in differentiating colonocytes and colon cancer (Scientific Reports, (2015), 5, 1, (17568), 10.1038/srep17568);TET-catalyzed 5-hydroxymethylcytosine regulates gene expression in differentiating colonocytes and colon cancer

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Chapman, Christopher G ^a   Mariani, Christopher J ^a   Wu, Feng ^a   Meckel, Katherine ^a   Butun, Fatma ^a   Chuang, Alice ^a   Madzo, Jozef ^a   Bissonette, Marc B ^a   Kwon, John H ^a   Godley, Lucy A ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5-HYDROXYMETHYLCYTOSINE; CYTOSINE; MIXED FUNCTION OXIDASE; ONCOPROTEIN; TET1 PROTEIN, HUMAN; TRANSCRIPTION FACTOR;

ADENOCARCINOMA; ANALOGS AND DERIVATIVES; BINDING SITE; CELL DIFFERENTIATION; COLON; COLON TUMOR; CYTOLOGY; GENE EXPRESSION REGULATION; GENETICS; HUMAN; METABOLISM; PATHOLOGY; TUMOR CELL LINE;

ADENOCARCINOMA; BINDING SITES; CELL DIFFERENTIATION; CELL LINE, TUMOR; COLON; COLONIC NEOPLASMS; CYTOSINE; GENE EXPRESSION REGULATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MIXED FUNCTION OXYGENASES; PROTO-ONCOGENE PROTEINS; TRANSCRIPTION FACTORS;

EID: 84949294655     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep24963     Document Type: Erratum

References (47)

1. Hammoud, S. S., Cairns, B. R. & Jones, D. A. Epigenetic regulation of colon cancer and intestinal stem cells. Current opinion in cell biology doi: 10.1016/j.ceb.2013.01.007 (2013).
2. Tahiliani, M. et al. Conversion of 5-methylcytosine to 5-hydroxymethylcytosine in mammalian DNA by MLL partner TET1. Science 324, 930-935 (2009).
3. Kriaucionis, S. & Heintz, N. The nuclear DNA base 5-hydroxymethylcytosine is present in Purkinje neurons and the brain. Science 324, 929-930 (2009).
4. Ito, S. et al. Tet Proteins Can Convert 5-Methylcytosine to 5-Formylcytosine and 5-Carboxylcytosine. Science 333, 1300-1303 (2011).
5. He, Y. F. et al. Tet-Mediated Formation of 5-Carboxylcytosine and Its Excision by TDG in Mammalian DNA. Science 333, 1303-1307 (2011).
6. Kaaij, L. T. J. et al. DNA methylation dynamics during intestinal stem cell differentiation reveals enhancers driving gene expression in the villus. Genome Biol 14, R50 (2013).
7. Sheaffer, K. L. et al. DNA methylation is required for the control of stem cell differentiation in the small intestine. Genes Dev. 28, 652-664 (2014).
8. Bock, C. et al. DNA methylation dynamics during in vivo differentiation of blood and skin stem cells. Mol Cell 47, 633-647 (2012).
9. Shearstone, J. R. et al. Global DNA demethylation during mouse erythropoiesis in vivo. Science 334, 799-802 (2011).
10. Moen, E. L. et al. New themes in the biological functions of 5-methylcytosine and 5-hydroxymethylcytosine. Immunological reviews 263, 36-49 (2015).
11. Mariani, C. J., Madzo, J., Moen, E. L., Yesilkanal, A. & Godley, L. A. Alterations of 5-hydroxymethylcytosine in human cancers. Cancers (Basel) 5, 786-814 (2013).
12. Madzo, J. et al. Hydroxymethylation at Gene Regulatory Regions Directs Stem/Early Progenitor Cell Commitment during Erythropoiesis. Cell Rep 6, 231-244 (2014).
13. Madzo, J., Vasanthakumar, A. & Godley, L. A. Perturbations of 5-Hydroxymethylcytosine Patterning in Hematologic Malignancies. Seminars in hematology 50, 61-69 (2013).
14. Verzi, M. P. et al. Differentiation-Specific Histone Modifications Reveal Dynamic Chromatin Interactions and Partners for the Intestinal Transcription Factor CDX2. Dev Cell 19, 713-726 (2010).
15. Christensen, J. et al. Defining new criteria for selection of cell-based intestinal models using publicly available databases. BMC Genomics 13, 274 (2012).
16. Madara, J. L., Stafford, J., Dharmsathaphorn, K. & Carlson, S. Structural analysis of a human intestinal epithelial cell line. Gastroenterology 92, 1133-1145 (1987).
17. Bertrand, F. E., Angus, C. W., Partis, W. J. & Sigounas, G. Developmental pathways in colon cancer: crosstalk between WNT, BMP, Hedgehog and Notch. Cell Cycle 11, 4344-4351 (2012).
18. Song, C.-X. et al. Selective chemical labeling reveals the genome-wide distribution of 5-hydroxymethylcytosine. Nat Biotechnol 29, 68-72 (2010).
19. Mariani, C. J. et al. TET1-Mediated Hydroxymethylation Facilitates Hypoxic Gene Induction in Neuroblastoma. Cell Rep 7, 1343-1352 (2014).
20. Heinz, S. et al. Simple combinations of lineage-determining transcription factors prime cis-regulatory elements required for macrophage and B cell identities. Mol Cell 38, 576-589 (2010).
21. ENCODE Project Consortium et al. An integrated encyclopedia of DNA elements in the human genome. Nature 489, 57-74 (2012).
22. Yu, M. et al. Base-resolution analysis of 5-hydroxymethylcytosine in the mammalian genome. Cell 149, 1368-1380 (2012).
23. Neri, F. et al. TET1 is a tumour suppressor that inhibits colon cancer growth by derepressing inhibitors of the WNT pathway. Oncogene 1-9 doi: 10.1038/onc.2014.356 (2014).
24. Ernst, J. & Kellis, M. ChromHMM: automating chromatin-state discovery and characterization. Nat Meth 9, 215-216 (2012).
25. Nestor, C. E. et al. Rapid reprogramming of epigenetic and transcriptional profiles in mammalian culture systems. Genome Biol 16, 11 (2015).
26. Jin, S.-G., Kadam, S. & Pfeifer, G. P. Examination of the specificity of DNA methylation profiling techniques towards 5-methylcytosine and 5-hydroxymethylcytosine. Nucleic Acids Res 38, e125 (2010).
27. Huang, Y. et al. The Behaviour of 5-Hydroxymethylcytosine in Bisulfite Sequencing. PLoS ONE 5, e8888 (2010).
28. Verzi, M. P., Shin, H., San Roman, A. K., Liu, X. S. & Shivdasani, R. A. Intestinal Master Transcription Factor CDX2 Controls Chromatin Access for Partner Transcription Factor Binding. Mol. Cell. Biol. 33, 281-292 (2012).
29. Haffner, M. C. et al. Global 5-hydroxymethylcytosine content is significantly reduced in tissue stem/progenitor cell compartments and in human cancers. Oncotarget 2, 627-637 (2011).
30. Jin, S. G. et al. 5-Hydroxymethylcytosine Is Strongly Depleted in Human Cancers but Its Levels Do Not Correlate with IDH1 Mutations. Cancer Res 71, 7360-7365 (2011).
31. Yang, H. et al. Tumor development is associated with decrease of TET gene expression and 5-methylcytosine hydroxylation. Oncogene 32, 663-669 (2013).
32. Chen, M. L. et al. Quantification of 5-Methylcytosine and 5-Hydroxymethylcytosine in Genomic DNA from Hepatocellular Carcinoma Tissues by Capillary Hydrophilic-Interaction Liquid Chromatography/Quadrupole TOF Mass Spectrometry. Clinical Chemistry 59, 824-832 (2013).
33. Kudo, Y. et al. Loss of 5-hydroxymethylcytosine is accompanied with malignant cellular transformation. Cancer Science 103, 670-676 (2012).
34. Lian, C. G. et al. Loss of 5-Hydroxymethylcytosine Is an Epigenetic Hallmark of Melanoma. Cell 150, 1135-1146 (2012).
35. Yamada, K., Ono, M., Perkins, N. D., Rocha, S. & Lamond, A. I. Identification and Functional Characterization of FMN2, a Regulator of the Cyclin-Dependent Kinase Inhibitor p21. Mol Cell 49, 922-933 (2013).
36. Zeng, W. et al. naked cuticle encodes an inducible antagonist of Wnt signalling. Nature 403, 789-795 (2000).
37. Hu, T. & Li, C. Convergence between Wnt-β -catenin and EGFR signaling in cancer. Mol Cancer 9, 236 (2010).
38. Li, C. et al. Myristoylated Naked2 escorts transforming growth factor alpha to the basolateral plasma membrane of polarized epithelial cells. Proc. Natl. Acad. Sci. USA 101, 5571-5576 (2004).
39. Motoyama, K. et al. Clinical Significance of BMP7 in Human Colorectal Cancer. Ann Surg Oncol 15, 1530-1537 (2008).
40. Ma, C. et al. Extracellular matrix protein ig-h3/TGFBI promotes metastasis of colon cancer by enhancing cell extravasation. Genes Dev. 22, 308-321 (2008).
41. Kang, Y. H. et al. The EF-hand calcium-binding protein tescalcin is a potential oncotarget in colorectal cancer. Oncotarget 5, 2149-2160 (2014).
42. Karolchik, D. et al. The UCSC Table Browser data retrieval tool. Nucleic Acids Res 32, D493-6 (2004).
43. Shen, L., Shao, N., Liu, X. & Nestler, E. ngs.plot: Quick mining and visualization of next-generation sequencing data by integrating genomic databases. BMC Genomics 15, 1-14 (2014).
44. Roberts, A. et al. Differential gene and transcript expression analysis of RNA-seq experiments with TopHat and Cufflinks. Nat Protoc 7, 562-578 (2012).
45. Losman, J.-A. et al. (R)-2-Hydroxyglutarate Is Sufficient to Promote Leukemogenesis and Its Effects Are Reversible. Science doi: 10.1126/science.1231677 (2013).
46. Zhu, J. et al. The UCSC Cancer Genomics Browser. Nat Meth 6, 239-240 (2009).
47. Seidelin, J. B., Horn, T. & Nielsen, O. H. Simple and efficient method for isolation and cultivation of endoscopically obtained human colonocytes. Am. J. Physiol. Gastrointest. Liver Physiol. 285, G1122-G1128 (2003).